SUBSCRIBE

Breaking News on Biopharmaceutical Development & Manufacturing

Top Headlines

dispatches from bioprocess international

Pall, Thermo Scientific, Fujifilm, Merck Millipore unveil new upstream, downstream offerings

The products, unveiled at BioProcess International in Boston this week, will help industry with their upstream and downstream processing and include an anti-CHO host cell protein detection kit, the first single-use fermentor, and a new mammalian expression platform.

More than a feeling, its a bioprocessing tradeshow!

Eli Lilly confident in its manufacturing for Insulin biosimilar market share

Eli Lilly’ manufacturing network will give it the edge in the glargine insulin market, the firm says having received tentative approval of its “Lantus look-alike” from the USFDA.

Argos begins construction on new biomanufacturing facility in North Carolina

Personalized immunotherapy developer Argos Therapeutics has broken ground on a new 100,000 square-foot biomanufacturing facility in Durham, North Carolina. 

Brand new invention to help biopharmas avoid cryoconcentration

Encountering vanilla ice is usually a dreadful experience, as anyone who has found uneven patches of frozen water in ice cream in a freezer can testify.

Dispatches from BioProcess International

Shift to single-use means end users ceding more control to suppliers, experts say

As single-use technology replaces traditional stainless steel technology in biomanufacturing, suppliers will own a larger portion of the supply chain, which is creating anxiety for end users such as Pfizer and Merck, experts say.

EC Oks 'dead' Abbvie-Shire takeover deal

Great news Abbvie; the European Commission (EC) has no problem with you buying Shire. 

Spotlight

Greenpeace: Industry needs greener disposal for single-use systems

Greenpeace: Industry needs greener disposal methods for single-use systems

Common environmentally practices for single-use systems must be adapted before industry “becomes too set in its ways,”...

Seattle Genetics, Genmab enter ADC collaboration worth up to $211m

Seattle Genetics, Genmab enter ADC collaboration worth up to $211m

Seattle Genetics and Genmab have entered into another antibody-drug conjugate (ADC)partnership under which Genmab will pay $11m...

Purple not the new orange: US FDA biopharmaceuticals list lacks dates

Purple not yet the new orange: US FDA biopharmaceuticals list lacks dates

A new list of biopharmaceuticals published by the US FDA provides limited information with only the entries...

Better together? Biosimilars sector says aye
infographic feature

Better together? biosimilars sector says aye

Partnerships are a mixed bag.For every oppressed group yearning to throw off the yoke of their imperialist...

Shifting pipelines drive AMRI to expand protein expression services

Shifting pipelines drive AMRI to expand protein expression services

AMRI has added protein expression and purification services to its drug discovery services citing the shift in...

Asthma: It’s a mAb, mAb, mAb, mAb world says analyst

Asthma: It’s a mAb, mAb, mAb, mAb world says analyst

Sanofi and Regeneron may overtake Roche and Astrazeneca at the head of the increasingly monoclonal antibody (mAb)...

On demand Supplier Webinars

Biosimilars: developing, manufacturing and selling
William Reed Business Media
All supplier webinars